Global Cardiology Electrodes Market to grow at a CAGR of 2.61% during the period 2016 - 2020; Finds New Report

Report forecast the global cardiology electrodes market to grow at a CAGR of 2.61% during the period 2016-2020.

Cardiology electrodes, composed of metal, lead, plastic, or cloth and electrode conducting gel, help convert ionic energy to electric current in the body and amplify the electric current for the diagnosis and treatment of diseases. These electrodes also help record the heart's electrical activity by placing them on the skin of the upper torso during ECG. This procedure helps diagnose cardiovascular diseases such as pulmonary embolism, cardiac murmurs, myocardial infarction, and cardiac dysrhythmias.

The report covers the present scenario and the growth prospects of the global cardiology electrodes market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:

• Stress ECG electrodes
• Neonatal ECG electrodes
• Long-term monitoring ECG electrodes
• Resting ECG electrodes
• Short-term monitoring ECG electrodes

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, the rising prevalence of cardiovascular diseases increases the need for associated diagnostic devices such as ECG systems. Cardiology electrodes are an integral component of these devices. A rise in the volume of cardiovascular disease diagnostics will increase the demand and development of cardiology electrodes.

Further, the report states that competition in the market is intense due to the presence of a few well-established vendors and many new and small companies that offer similar products. This has led to price wars among vendors.

Global Cardiology Electrodes Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Cardiology Electrodes Market: 3M Co., Ambu A/S, ConMed Corp., Leonhard Lang GmbH, and Medtronic plc.

Other Prominent Vendors in the market are: ADInstruments, Bio-Protech, Bio-Lead-Lok-B, Cardinal Health, Diagramm Halbach, GE Healthcare (a subsidiary of GE), Medtel, Medico Electrodes International, NIKOMED USA, Philips Healthcare, Qingdao Bright, Romsons Scientific & Surgical, VacuMed, VERMED, and Thought Technology.

Market driver

• Demand for cardiovascular disease diagnostics
• For a full, detailed list, view our report

Market challenge

• Pricing pressure
• For a full, detailed list, view our report

Market trend

• Development of dry electrodes
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 62 pages and 38 Exhibit “Global Cardiology Electrodes Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Medical electrodes: Overview, Global medical electrodes market, Cardiology electrodes: Market landscape, Market segmentation by application, Market segmentation of cardiology electrodes by usability, Market segmentation of cardiology electrodes by adhesion type, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/JuT

Related Reports;

Global Allergy Immunotherapies Market 2016-2020 - Visit at - http://mrr.cm/Juc

Global Cerebral and Tissue Oximetry Devices Market 2016-2020 - Visit at - http://mrr.cm/Jup

Global Biopsy Devices - Analysis and Market Forecasts; New Report Launched

The biopsy devices space across the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India, will rise modestly in value from $915.2 million to over $1.16 billion by 2022, at a CAGR of 3.5%. Emerging countries in the Asia-Pacific region, such as India and China, will have growth rates similar to the global CAGR due to increased market access of each country's population to healthcare resources. Although the market value is rising, there are several barriers preventing this growth from being particularly striking. In the US, for example, the benefit of routine screening for prostate cancer has come under scrutiny, as sophisticated clinical trials have revealed that screening has a minimal impact on cancer-related mortality.

The current biopsy devices market also faces substantial long-term competition, as start-up companies and large medical device manufacturers try to employ new technologies to make the diagnosis of cancer even less invasive without the need for target tissue extraction. Two such technologies include optical and liquid biopsies, which seek to replace physical ones. Unlike traditional biopsy techniques, which involve extracting a tissue sample from the patient, optical biopsies capitalize on the properties of light to enable the operator to make real-time diagnostic assessments without the need for extracting tissues and examining them under a microscope. Liquid biopsy technology is based on circulating tumor cells or circulating DNA, and would only require a sample of patient's blood in order to obtain key information on the cells' physical and biological properties.

MediPoint: Biopsy Devices - Global Analysis and Market Forecasts report provides analysis of the biopsy devices space across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India, including annualized market data from 2013 and forecast until 2022.

Key questions answered:

• What are the procedure volumes for different biopsy procedures in different countries? How will the volumes change in the next five years?
• Growth in the biopsy devices market is driven by an increasing number of cancer incident cases. What are the current numbers of cancer diagnosed cases in different geographies? How will the numbers change in the upcoming years?
• Biopsy guns are most frequently used biopsy devices and core needle biopsy devices gain popularity over fine needle aspiration devices. What are the current adoption trends of different types of biopsy device in different geographies? How will the adoption trends evolve in the near future?
• There are various types of biopsy devices and different companies have a different strategic product focus. Who are the leading players in the biopsy devices market? 

For more information Visit at: http://mrr.cm/Juq

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices 

Global Healthcare Analytics Market is expected to grow CAGR to reach $33,542 million by 2022; Finds New Report

Healthcare analytics is one of the emerging areas of healthcare services. It extensively uses information technology tools, data, statistical and qualitative analysis, explanatory and predictive modeling. The analytics help the healthcare organizations in reducing the hospital stays of patients, meeting regulatory compliance, improved quality care, preclusion of chronic diseases, and fraud detection.

Global healthcare analytics market is segmented into tool types, applications, components, delivery modes, end users and geography. Tool types market is further partitioned into descriptive, predictive and prescriptive analytics. Components are classified into hardware, software and services segments. Mode of delivery is segmented into on-promise, web-hosted and cloud-based models. Depending on the end users, the healthcare analytics market is sectioned into payers, providers, HIE and others.

This report studies the global healthcare analytics market over the forecast period 2015 to 2022. The market is expected to grow at a double digit CAGR to reach $33,542 million by 2022. Federal healthcare mandates, rising healthcare costs and pressure to reduce, emergence of big data and advancements in analytical technologies, digitalization of healthcare, personalized medicine are some of the factors driving the healthcare analytics market growth. Factors such as security issues and data breaches, lack of skilled labor with analytical skills, lack of patient data confidentiality and transparency, lack of interoperability, functional gap between payers and providers, increase in governmental regulation, and reimbursement issues are hampering the market growth.

Geographically the market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America dominated the healthcare analytics market with a largest share which is driven by U.S. centralized healthcare mandates such as the Patient Protection and Affordable Care Act (PPACA) and meaningful use. These initiatives assist to improve the acceptance of Electronic Health Records (EHRs) and Healthcare Information Exchange (HIE), thus improving the usage of analytics to influence the generated data. The European market is expected to be the second largest market, growing at a lower rate mainly due to the economic crisis. The Asian market is fairly new to medical analytics; however, the increasing IT skills, outsourcing trend and healthcare IT adoption will force this market to emerge into fast growing market in the future.

The healthcare analytics market is a fragmented market with key players operating in the field of EHR & EMR platforms, cross-vertical service providers and healthcare analytical tool/service providers. The major players in the market are Allscripts Healthcare Solution, Inc. (U.S.), Cerner Corporation (U.S.), Epic Systems (U.S.), IBM Corporation (U.S.), Information Builders, Inc. (U.S.), McKesson Corporation (U.S.), MedeAnalytics, Inc. (U.S.), Oracle Corporation (U.S.), Optum, Inc. (U.S.), and Verisk Analytics (U.S.).

Spanning over 306 pages “Healthcare Analytics Global Market - Forecast To 2022” report covers Executive Summary, Introduction, Market Overview, Global Healthcare Analytics Market, By Tool Type, Global Healthcare Analytics Market, By Application, Global Healthcare Analytics Market, By Component, Healthcare Analytics Market, By Delivery Mode, Global Healthcare Analytics Market, By End-User, Regional Market Analysis, Company Developments, Company Profiles. This report Covered 97 Cpmpanies Few are - ALLSCRIPTS HEALTHCARE SOLUTIONS, INC., CERNER CORPORATION, EPIC SYSTEMS CORPORATION, IBM CORPORATION, INFORMATION BUILDERS, INC, MCKESSON CORPORATION, MEDEANALYTICS, INC, UNITED HEALTH GROUP (OPTUM, INC), ORACLE CORPORATION, VERISK ANALYTICS, LIST OF COMPANIES MENTIONED IN THE REPORT.

For more information Visit at: http://mrr.cm/JuM

Find all Healthcare reports at : http://www.marketresearchreports.com/healthcare

United States Surgical Navigation Systems Industry 2016 New Report Now Available From MarketResearchReports.com

The United States Surgical Navigation Systems Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Surgical Navigation Systems industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Surgical Navigation Systems market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Surgical Navigation Systems industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 151 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Spanning over 130 pages “United States Surgical Navigation Systems Industry 2016 Market Research Report” report covers Industry Overview, Manufacturing Cost Structure Analysis of Surgical Navigation Systems, Technical Data and Manufacturing Plants Analysis, Production Analysis of Surgical Navigation Systems by Regions, Type, and Applications, Consumption Volume and Consumption Value Analysis of Surgical Navigation Systems by Regions, Analysis of Surgical Navigation Systems Production, Supply, Sales and Market Status 2011-2016, Analysis of Surgical Navigation Systems Industry Key Manufacturers, Price and Gross Margin Analysis, Marketing Trader or Distributor Analysis of Surgical Navigation Systems, Development Trend of Surgical Navigation Systems Industry 2016-2021, Industry Chain Suppliers of Surgical Navigation Systems with Contact Information, New Project Investment Feasibility Analysis of Surgical Navigation Systems, Conclusion of the United States Surgical Navigation Systems Industry 2016 Market Research Report.

For more information Visit at: http://mrr.cm/JBT

Related Reports :

United States Overactive Bladder Industry 2016 Market Research Report - Visit at - http://mrr.cm/JBq

United States Orthopedic Soft Tissue Repair Devices Industry 2016 Market Research Report - Visit at - http://mrr.cm/JBc

Global Molecular Diagnostics Market is expected to reach more than US$ 30 Billion by 2021; Finds New Report

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market.

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment.  Oncology test controls nearly 25% market share by the year 2021.

Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.

The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges

Global Molecular Diagnostics Market has been analyzed from 6 viewpoints:

1) Market and Forecast

2) Application Wise Market & Forecast

3) Geographical Market & Forecast

4) Technology Wise Market & Forecast

5) Company Wise Molecular Diagnostics sales & Forecast

6) Market Growth Drivers & Challenges

The following application segments of the molecular diagnostics market are detailed with size and six year forecast.

• Infectious Disease Testing
• Cardiovascular Disease Testing
• Oncology Testing
• Neurological Disorders Testing
• Food Pathogen Detection Testing
• Genetic Testing
• Blood Screening
• Tissue Typing (HLA Testing)
• Others Molecular Testing

Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast.

• PCR Based Test
• PCR Related Technologies
• Non–PCR Test
• Fish & Innovations Testing
• Biochips/Microarrays
• Biosensors
• Molecular Imaging
• Other Technologies

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

• North America
• Europe
• Japan
• China
• India
• Brazil
• Mexico
• Korea
• Rest of the world

The following companies of the molecular diagnostics market are detailed with size and six year forecast.

• Roche
• Abbott Laboratories
• Myriad Genetics
• Qiagen
• Cephied
• Becton Dickinson
• Biomerieux
• Other Companies

Spanning over 117 pages “Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021” report covers Executive Summary, Global Molecular Diagnostics Market & Forecast (2010 – 2021), Global Molecular Diagnostics Market Share (2010 – 2021), Global Molecular Diagnostics Market – Country wise Analysis (2010 – 2021), Global – Molecular Diagnostics Market – Application wise Analysis (2010 – 2021), Global – Molecular Diagnostics Market – Technology wise Analysis (2010 – 2021), Global – Molecular Diagnostics Sales Analysis – Company wise, Global Molecular Diagnostics Market – Growth Drivers, Global Molecular Diagnostics Market – Challenges.

For more information Visit at: http://mrr.cm/JBw

Find all Diagnostics report at: http://www.marketresearchreports.com/diagnostics

Global Heart Valves Market to grow at a CAGR of 14.28% during the period 2016 - 2020; Finds New Report

Report forecast the global heart valves market to grow at a CAGR of 14.28% during the period 2016-2020.

Heart valves are prosthetic cardiovascular medical devices used to replace a defective heart valve. They can be biological, tissue or mechanical. Manufacturers develop mechanical heart valves from synthetic materials such as pyrolytic carbon, titanium alloy, and cobalt-based alloys and tissue heart valves from bovine, porcine, and human tissues. They also develop transcatheter heart valves with a combination of tissue and synthetic materials. Devices developed using human tissues are known as allografts or homografts. Medical personnel implant transcatheter heart valves through the transfemoral approach (via the femoral artery) and transapical approach (via a small chest incision). Medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

The report covers the present scenario and the growth prospects of the global heart valves market for 2016-2020. To calculate the market size, we consider revenue generated from the sales of prosthetic heart valve products such as:

• Mechanical heart valves: Caged ball, tilting disc, and bileaflet valves
• Tissue heart valves: Stented and stentless tissue valves
• Transcatheter heart valves: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) devices

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, a key growth driver is the implementation of minimally invasive procedures. Physicians use invasive and MI procedures, such as sternotomy and thoracotomy, to implant mechanical, tissue, and transcatheter heart valves in people with heart valve diseases. However, invasive methods can cause pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs. This has led physicians to opt for minimally invasive surgeries for device implantation. Minimally invasive catheter-based procedures help improve the quality of life. These procedures for the implantation of heart valves have proven to be safe and efficient. They reduce the need for blood transfusions, the risk of infections, and hospital stays; cause minimal blood loss and less pain and scarring; and lead to rapid healing and recovery and better clinical outcome.

Further, the report states that one challenge that could restrict market growth is the expense involved in heart valve replacement procedures. Heart valve replacement procedures are recent advances in the field of medical technology and expensive. This results in people with heart valve diseases avoiding associated replacement procedures.

Global Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global heart valves market: Edwards Lifesciences, LivaNova, Medtronic and St. Jude Medical.

Other Prominent Vendors in the market are: Abbott Laboratories, Braile Biomedica, Cardious, Colibri Heart Valve, corlife OHG, JenaValve Technology, Lepu Medical Technology (Beijing), Meril Life Sciences, Neovasc, ON-X Life Technologies, Pulmonx, Roskardioinvest, and SYMETIS.

Market driver

• Implementation of minimally invasive procedures
• For a full, detailed list, view our report

Market challenge

• v
• For a full, detailed list, view our report

Market trend

• Use of stentless tissue valves
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 67 pages and 45 Exhibit “Global Heart Valves Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Cost analysis, Market segmentation by product, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://mrr.cm/JXu

Related Reports;

Global Hemoglobin Testing Market 2016-2020 - Visit at - http://mrr.cm/JXL

Global Insulin Pumps Market 2016-2020 - Visit at - http://mrr.cm/JXb

Global Cancer Diagnostics Devices Market to grow at a CAGR of 18.07% during the period 2016 - 2020; Finds New Report

Report forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, a key growth driver is the demand for personalized medicines. Proteins and genes control and manage the biochemical functions of the body. Any defect in the structure of a particular protein or gene can lead to specific conditions and disorders. The production of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized based on an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes.

Further, the report states that one challenge that could impact market growth is the high cost of developing companion diagnostics.

Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global cancer diagnostics devices market: Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, and Roche Diagnostics.

Other Prominent Vendors in the market are: Affymetrix, Ambry Genetics, Annoroad, Aviva Biosciences, Biochain, Bio-Rad, Cancer Genetics, Cepheid, CompanionDx, DiagnoCure, Epic Sciences, Epigenomics, Genomic Health, HalioDX, Hologic, Illumina, Myriad Genetics, Thermo Fisher Scientific, Ventana Medical Systems, and Vysis.

Market driver

• Demand for personalized medicines
• For a full, detailed list, view our report

Market challenge

• High cost of developing companion diagnostics
• For a full, detailed list, view our report

Market trend

• Demand for personalized medicines
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 67 pages and 39 Exhibit “Global Cancer Diagnostics Device Market 2016 - 2020” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Cancer statistics, Reimbursement and coverage: An overview, Cancer diagnostic devices: Pricing scenario, Market segmentation by product, Market segmentation by cancer type, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendors, Appendix.

For more information Visit at: http://mrr.cm/JBB

Related Reports;

Global Gonorrhea Diagnostics Market 2016-2020 - Visit at - http://mrr.cm/JB2

Global Hemostats and Tissue Sealants Market 2016-2020 - Visit at - http://mrr.cm/JB6

Global Autoimmune Disease Diagnostics Market 2016-2020 - Visit at - http://mrr.cm/JBu